OLVAX
Price
$21.87
Change
-$0.01 (-0.05%)
Updated
Sep 8 closing price
Net Assets
5.29B
VVIAX
Price
$71.07
Change
-$0.12 (-0.17%)
Updated
Sep 8 closing price
Net Assets
202.84B
Interact to see
Advertisement

OLVAX vs VVIAX

Header iconOLVAX vs VVIAX Comparison
Open Charts OLVAX vs VVIAXBanner chart's image
JPMorgan Large Cap Value A
Price$21.87
Change-$0.01 (-0.05%)
VolumeN/A
Net Assets5.29B
Vanguard Value Index Adm
Price$71.07
Change-$0.12 (-0.17%)
VolumeN/A
Net Assets202.84B
OLVAX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OLVAX vs. VVIAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OLVAX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. OLVAX (5.29B). VVIAX pays higher dividends than OLVAX: VVIAX (2.10) vs OLVAX (0.92). OLVAX was incepted earlier than VVIAX: OLVAX (34 years) vs VVIAX (25 years). OLVAX (1.01) is less costly to investors than VVIAX (0.05). OLVAX is a more actively managed with annual turnover of: 167.00 vs. VVIAX (9.00). OLVAX has a lower initial minimum investment than VVIAX: OLVAX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. OLVAX (3.75). VVIAX return over 5 years is better than : 70.16 vs. OLVAX (64.78).
OLVAXVVIAXOLVAX / VVIAX
Total Expense Ratio0.930.051,860%
Annual Report Gross Expense Ratio1.010.052,020%
Fund Existence34 years25 years-
Gain YTD9.0407.850115%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets5.29B203B3%
Annual Yield % from dividends0.922.1043%
Returns for 1 year3.757.7448%
Returns for 3 years23.0336.6163%
Returns for 5 years64.7870.1692%
Returns for 10 years67.71131.6151%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity